SARS-CoV-2 pandemic and the need for transplant-oriented trials

Transpl Int. 2020 Aug;33(8):966-968. doi: 10.1111/tri.13626. Epub 2020 May 14.

Authors

Gianluigi Zaza¹, Claudia Benedetti¹, Miguel Fribourg², Umberto Maggiore³, Jamil Azzi⁴, Leonardo V Riella⁴, Paolo Cravedi²

Affiliations

¹ Renal Unit, Department of Medicine, University Hospital of Verona, Verona, Italy.
² Department of Medicine, Icahn School of Medicine at Mount Sinai, Translational Transplant Research Center, New York, NY, USA.
³ UO Nefrologia, Dipartimento di Medicina e Chirurgia, Azienda Ospedaliera-Universitaria Parma, Università di Parma, Parma, Italy.
⁴ Renal Division, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.

No abstract available

Publication types

Letter

MeSH terms

Betacoronavirus*
COVID-19
COVID-19 Drug Treatment
Clinical Trials as Topic*
Coronavirus Infections / drug therapy
Coronavirus Infections / epidemiology*
Coronavirus Infections / therapy*
Humans
Pandemics*
Patient Selection*
Pneumonia, Viral / epidemiology*
Pneumonia, Viral / therapy*
SARS-CoV-2
Translational Research, Biomedical
Transplant Recipients
Transplants*